Elicio Therapeutics, Inc. (ELTX) Operating cash flow 2020–2025
Elicio Therapeutics, Inc. (ELTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$37.0MFY2025 · since FY2020: -$22.9M → -$37.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.0M | +0.3% |
| FY2024 | -$37.1M | -13.4% |
| FY2023 | -$32.7M | -47.4% |
| FY2022 | -$22.2M | +57.9% |
| FY2021 | -$52.6M | -130.0% |
| FY2020 | -$22.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ELTX financial trends
ELTX RevenueELTX Net incomeELTX Net marginELTX Gross profitELTX Gross marginELTX Operating incomeELTX Operating marginELTX Free cash flowELTX Capital expendituresELTX Return on equityELTX Stock buybacksELTX Dividends paidELTX Total assetsELTX Total liabilitiesELTX Shareholders’ equityELTX overview →